Novartis Scemblix receives positive CHMP opinion for newly diagnosed CML in adults

Basel: Novartis has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting marketing authorization for…

Continue ReadingNovartis Scemblix receives positive CHMP opinion for newly diagnosed CML in adults

NEET PG Counselling 2025: MCC notifies NMC interim guidelines for PwBD candidates, details

New Delhi: The National Medical Commission (NMC) issued Interim Guidelines on Assessment Method for Granting Admission in Postgraduate Courses to Persons with Benchmark Disabilities (PwBD) for the academic year 2025-26, in accordance…

Continue ReadingNEET PG Counselling 2025: MCC notifies NMC interim guidelines for PwBD candidates, details

Strides, Incepta partner to expand women health access with WHO prequalified contraceptive

Bangalore: Strides Pharma Science Limited has announced that one of its step-down wholly owned subsidiary will market the WHO-prequalified generic version of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Africa, strengthening women’s…

Continue ReadingStrides, Incepta partner to expand women health access with WHO prequalified contraceptive

CDSCO Panel Flags Small Sample Size, Limited Scope, Asks Zydus to Rework Phase IV Letermovir Study

New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has directed Zydus Lifesciences Ltd to revise and resubmit the Phase IV Clinical Trial protocol…

Continue ReadingCDSCO Panel Flags Small Sample Size, Limited Scope, Asks Zydus to Rework Phase IV Letermovir Study